Granzyme A Polyclonal Antibody

Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The granzyme A described here is a T cell- and natural killer cell-specific serine protease that may function as a common component necessary for lysis of target cells by cytotoxic T lymphocytes and natural killer cells.

The Granzyme A Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of Granzyme A protein in various biological samples. This antibody is produced using state-of-the-art techniques, ensuring high purity and quality.

Granzyme A is a serine protease that plays a crucial role in immune responses, particularly in cytotoxic T lymphocytes and natural killer cells. It is involved in the induction of apoptosis in target cells, making it an essential mediator of immune defense against infected or transformed cells.

The Granzyme A Polyclonal Antibody has been extensively validated for its specificity and sensitivity, making it an ideal choice for researchers studying the role of Granzyme A in various physiological and pathological processes. It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results.

This antibody is suitable for a wide range of applications, including Western blotting, immunohistochemistry, and flow cytometry. It is compatible with various sample types, including cell lysates, tissue homogenates, and serum.

With its high affinity and specificity, the Granzyme A Polyclonal Antibody offers researchers a valuable tool for investigating the function and regulation of Granzyme A in diverse biological contexts. Its superior performance and reliability make it an indispensable asset in immunological research.